(Q35928858)

11 August 2017

1 reference

title

Population pharmacokinetics III: design, analysis, and application of population pharmacokinetic Studies (English)

1 reference

11 August 2017

1 reference

Ene I Ette

1

1 reference

11 August 2017

Paul J Williams

series ordinal

2

1 reference

11 August 2017

James R Lane

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

26 October 2004

1 reference

Annals of Pharmacotherapy

11 August 2017

published in

1 reference

11 August 2017

volume

38

1 reference

11 August 2017

issue

12

1 reference

11 August 2017

page(s)

2136-2144

1 reference

Population pharmacokinetics I: background, concepts, and models

11 August 2017

cites work

1 reference

Population pharmacokinetics II: estimation methods

21 January 2018

1 reference

The process of knowledge discovery from large pharmacokinetic data sets

21 January 2018

1 reference

Model appropriateness and population pharmacokinetic modeling

21 January 2018

1 reference

Population Pharmacokinetics/Dynamics*

21 January 2018

1 reference

The importance of modeling interoccasion variability in population pharmacokinetic analyses

21 January 2018

1 reference

Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria

21 January 2018

1 reference

Population pharmacokinetics. A regulatory perspective.

21 January 2018

1 reference

Clinical trial simulation in drug development

21 January 2018

1 reference

Comparison of some practical sampling strategies for population pharmacokinetic studies.

21 January 2018

1 reference

Design evaluation for a population pharmacokinetic study using clinical trial simulations: a case study.

21 January 2018

1 reference

Analysis of animal pharmacokinetic data: performance of the one point per animal design

21 January 2018

1 reference

Inference and missing data

21 January 2018

1 reference

Stability and performance of a population pharmacokinetic model

21 January 2018

1 reference

Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check

21 January 2018

1 reference

Evaluation of population (NONMEM) pharmacokinetic parameter estimates.

21 January 2018

1 reference

A population pharmacokinetic model for docetaxel (Taxotere): model building and validation

21 January 2018

1 reference

Role of population pharmacokinetics in drug development. A pharmaceutical industry perspective

21 January 2018

1 reference

Population pharmacokinetics. Theory and clinical application

21 January 2018

1 reference

Impact of population pharmacokinetic-pharmacodynamic analyses on the drug development process: experience at Parke-Davis

21 January 2018

1 reference

Nonlinear mixed effects modeling of single dose and multiple dose data for an immediate release (IR) and a controlled release (CR) dosage form of alprazolam

21 January 2018

1 reference

Application of NONMEM to routine bioavailability data

21 January 2018

1 reference

Estimating bioavailability when clearance varies with time

21 January 2018

1 reference

A semiparametric method for describing noisy population pharmacokinetic data

21 January 2018

1 reference

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

Clinical Pharmacy: Case Studies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E260

1 reference

release_4yseplxe35fejgjtsojp5emtru

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4yseplxe35fejgjtsojp5emtru

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference